PAPER Zhu J, Xu X, Liang Y, Zhu R
SEARCH RESULTS
19580 RESULTS
PAPER Rezaei O, Nateghinia S, Estiar MA, Taheri M, Ghafouri-Fard S
Assessment of the role of non-coding RNAs in the pathophysiology of Parkinson's disease.
Eur J Pharmacol. 2021 Apr 5;896:173914. Epub 2021 Jan 26 PubMed: 33508286PAPER Pike AF, Varanita T, Herrebout MA, Plug BC, Kole J, Musters RJ, Teunissen CE, Hoozemans JJ, Bubacco L, Veerhuis R
α-Synuclein evokes NLRP3 inflammasome-mediated IL-1β secretion from primary human microglia.
Glia. 2021 Jun;69(6):1413-1428. Epub 2021 Jan 28 PubMed: 33506583PAPER Gento-Caro Á, Vilches-Herrando E, García-Morales V, Portillo F, Rodríguez-Bey G, González-Forero D, Moreno-López B
Interfering with lysophosphatidic acid receptor edg2/lpa1 signalling slows down disease progression in SOD1-G93A transgenic mice.
Neuropathol Appl Neurobiol. 2021 Jan 28; PubMed: 33508894PAPER Killoy KM, Pehar M, Harlan BA, Vargas MR
Altered expression of clock and clock-controlled genes in a hSOD1-linked amyotrophic lateral sclerosis mouse model.
FASEB J. 2021 Feb;35(2):e21343. PubMed: 33508151PAPER Lin CH, Chiu CC, Lane HY
Trough Melatonin Levels Differ between Early and Late Phases of Alzheimer Disease.
Clin Psychopharmacol Neurosci. 2021 Feb 28;19(1):135-144. PubMed: 33508797PAPER Zhang J, Liu R, Zhang D, Zhang Z, Zhu J, Xu L, Guo Y
Neuroprotective effects of maize tetrapeptide-anchored gold nanoparticles in Alzheimer's disease.
Colloids Surf B Biointerfaces. 2021 Apr;200:111584. Epub 2021 Jan 20 PubMed: 33508658PAPER Varshney V, Garabadu D
Ang (1-7)/Mas receptor-axis activation promotes amyloid beta-induced altered mitochondrial bioenergetics in discrete brain regions of Alzheimer's disease-like rats.
Neuropeptides. 2021 Apr;86:102122. Epub 2021 Jan 9 PubMed: 33508525PAPER Setti SE, Raymick J, Hanig J, Sarkar S
In vivo demonstration of Congo Red labeled amyloid plaques via perfusion in the Alzheimer disease rat model.
J Neurosci Methods. 2021 Apr 1;353:109082. Epub 2021 Jan 25 PubMed: 33508413PAPER Coria-Lucero C, Ledezma C, Castro A, Delgado S, Anzulovich AC, Navigatore-Fonzo L
Daily oscillation of cognitive factors is modified in the temporal cortex of an amyloid β(1-42)-induced rat model of Alzheimer's disease.
Brain Res Bull. 2021 May;170:106-114. Epub 2021 Jan 27 PubMed: 33508401PAPER Mahmoudi E, Lin P, Peterson MD, Meade MA, Tate DG, Kamdar N
Traumatic Spinal Cord Injury and Risk of Early and Late Onset Alzheimer's Disease and Related Dementia: Large Longitudinal Study.
Arch Phys Med Rehabil. 2021 Jun;102(6):1147-1154. Epub 2021 Jan 27 PubMed: 33508336PAPER Saha J, Dean DN, Dhakal S, Stockmal KA, Morgan SE, Dillon KD, Adamo MF, Levites Y, Rangachari V
Biophysical characteristics of lipid-induced Aβ oligomers correlate to distinctive phenotypes in transgenic mice.
FASEB J. 2021 Feb;35(2):e21318. PubMed: 33508158PAPER Minicucci J, Alfond M, Demuro A, Gerberry D, Latulippe J
Quantifying the dose-dependent impact of intracellular amyloid beta in a mathematical model of calcium regulation in xenopus oocyte.
PLoS One. 2021;16(1):e0246116. Epub 2021 Jan 28 PubMed: 33508037PAPER Kelliny S, Bobrovskaya L, Zhou XF, Upton R
Pharmacokinetic Modelling of Human Recombinant Protein, p75ECD-Fc: A Novel Therapeutic Approach for Treatment of Alzheimer's Disease, in Serum and Tissue of Sprague Dawley Rats.
Eur J Drug Metab Pharmacokinet. 2021 Mar;46(2):235-248. Epub 2021 Jan 28 PubMed: 33507523PAPER Zhang N, Yu X, Xie J, Xu H
New Insights into the Role of Ferritin in Iron Homeostasis and Neurodegenerative Diseases.
Mol Neurobiol. 2021 Jun;58(6):2812-2823. Epub 2021 Jan 28 PubMed: 33507490Current Filters
- Date Range : Apr 2020 to Apr 2021 x